Industry & newsNews & newsletter

Industry news

News from the Swiss biotech industry: featured stories, media releases from member companies, the monthly newsletter and the Swiss Biotech Report.

Featured

Latest news

Nov 4, 2026abc biopply and Panome Bio collaborateabc biopply ag

Oct 28, 2026DEBRA Research invests in Topadur

Oct 19, 2026Nouscom raises EUR 120 million in financingNouscom AG

Oct 11, 2026Newron flash update - Jumping the FDA hurdles should be manageablevaluationLAB AG

Oct 9, 2026Pharvaris: Phase 3 study shows efficacy in angioedema attacks treatmentPharvaris GmbH

Oct 9, 2026iOnctura reveals novel inhibition mechanismIOnctura SA

Oct 8, 2026abc biopply and VoxCell partner on vascularized tissue modelsabc biopply ag

Oct 5, 2026Pharvaris: Study identifies gaps in hereditary angioedema carePharvaris GmbH

Oct 5, 2026ten23 health: Aseptic manufacturing capacity expanded in Vispten23 health AG

Sep 30, 2026Leman Biotech: CAR-T therapy cleared for three trials in ChinaLeman Biotech Lausanne SA

From the Swiss Biotech Report

Guest editorialAndré Hoffmann, Vice Chairman of Roche Holding and Co-Chair, World Economic Forum

Editorial Swiss Biotech Report 2026Michael Altorfer, CEO, Swiss Biotech Association

Swiss biotech 2025: Facts & figuresFrederik Schmachtenberg & Helena Rosa, EY

The year in chartsFrederik Schmachtenberg & Helena Rosa, EY

Export statistics: Biotech products as a driving force of the Swiss export economyJan Lucht, scienceindustries

Publication

Swiss Biotech Report 2026

Explore the latest trends, innovation and key facts shaping the Swiss biotech industry.

Download PDF Read online

Industry & news

More pages in this section